Treatment - Page 2 of 471 Posts on Medivizor

Evaluating the long-term effectiveness and safety of adding abiraterone acetate and prednisolone with or without enzalutamide in patients with metastatic prostate cancer starting androgen-deprivation therapy.

Posted by Medivizor on May 26, 2024 in Prostate cancer | 0 comments

In a nutshell The study evaluated the long-term effectiveness and safety outcomes of adding abiraterone acetate (AA; Zytiga) and prednisolone (P; Deltasone) with or without enzalutamide (Xtandi) in patients with metastatic prostate cancer (PC) starting androgen-deprivation therapy (ADT). The data showed that enzalutamide and AA+P should not be combined...

Evaluating the effects of dance style and training duration in improving balance in patients with Parkinson’s disease.

Posted by Medivizor on Oct 22, 2023 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the effects of dance style and training duration in improving balance in patients with Parkinson’s disease (PD). The data showed that dance-based interventions of more than 12 weeks could effectively improve balance in these patients. Some background PD is a disorder in which part of the brain is progressively...

Evaluating the effectiveness and safety of immune checkpoint inhibitors given before surgery for the treatment of resectable mucosal melanoma.

Posted by Medivizor on Oct 22, 2023 in Melanoma | 0 comments

In a nutshell This study evaluated the effectiveness and safety of immune checkpoint inhibitors (ICIs) given before surgery for the treatment of patients with resectable mucosal melanoma. The data showed that ICIs given before surgery were effective with manageable side effects for these patients. Some background Melanoma is an aggressive type of skin...

Comparing the effectiveness and safety of chemotherapy-based combination therapies as first-line treatment for advanced non-small cell lung cancer with negative PD-L1.

Posted by Medivizor on Oct 22, 2023 in Lung cancer | 0 comments

In a nutshell This study compared the effectiveness and safety of chemotherapy-based combination therapies for the treatment of patients with advanced non-small cell lung cancer (NSCLC) with negative PD-L1 expression. The data showed that pembrolizumab (Keytruda) plus chemotherapy combination was the best treatment regimen for improving overall survival...

Evaluating the effectiveness and safety of TAS-102 plus Yttrium-90 radioembolization for the treatment of patients with colorectal cancer liver metastasis.

Posted by Medivizor on Oct 22, 2023 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the effectiveness and safety of TAS-102 (Lonsurf; trifluridine-tipiracil) plus Yttrium-90 (Y-90) radioembolization (RE) for patients with colorectal cancer liver metastasis (CRLM) who are unresponsive to chemotherapy. The data showed that TAS-102 plus RE was safe and effective in these patients. Some background...

Evaluating the effectiveness of antibiotic bone cement for infected diabetic foot wounds

Posted by Medivizor on Sep 17, 2023 in Diabetes mellitus | 0 comments

In a nutshell The study investigated the efficacy of antibiotic bone cement for infected diabetic foot wounds. The study found that antibiotic cement gave promising results for the management of diabetic foot-infected wounds. Some background Diabetes is a condition that affects the body’s blood glucose level. Diabetes requires constant treatment...

Comparing the effectiveness of combined therapy of bortezomib, melphalan, and prednisone with versus without daratumumab in patients with multiple myeloma ineligible for a transplant

Posted by Medivizor on Sep 17, 2023 in Multiple Myeloma | 0 comments

In a nutshell The study evaluated the effectiveness of combined therapy of bortezomib (Velcade), melphalan (Alkeran), and prednisone (Deltasone) with (D-VMP) versus without (VMP) daratumumab (Darzalex) in transplant-ineligible patients newly diagnosed with multiple myeloma (MM). The study concluded that D-VMP was more effective than using...

Evaluating the long-term effectiveness and safety of nivolumab and AVD chemotherapy combination in patients with early-stage unfavorable classical Hodgkin lymphoma.

Posted by Medivizor on Sep 17, 2023 in Hodgkin's lymphoma | 0 comments

In a nutshell This study reported the long-term safety and effectiveness of nivolumab (Opdivo; N) + AVD (doxorubicin, vinblastine, and dacarbazine) chemotherapy combinations in patients with early-stage unfavorable classical Hodgkin lymphoma (cHL). The data showed that the N+AVD combination is safe and highly effective over the long term for these...

Evaluating the effectiveness and safety of continuous subcutaneous foslevodopa-foscarbidopa for the treatment of motor fluctuations in patients with Parkinson’s disease.

Posted by Medivizor on Sep 17, 2023 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the effectiveness and safety of continuous subcutaneous foslevodopa-foscarbidopa (ABBV-951) for the treatment of motor fluctuations in patients with Parkinson’s disease (PD). The data showed that continuous subcutaneous foslevodopa-foscarbidopa significantly improved motor fluctuations in these patients. Some...

Comparing the effectiveness and safety of 5 injections of OnabotulinumtoxinA versus the standard 20 injections for the treatment of patients with overactive bladder.

Posted by Medivizor on Sep 17, 2023 in Overactive bladder | 0 comments

In a nutshell This study compared the effectiveness and safety of 5 injections of onabotulinumtoxinA (OBTA; Botox) versus the standard 20 injections for the treatment of patients with overactive bladder (OAB). The study found that a reduced technique of 5 injections of OBTA was safe and as effective as the standard technique of 20 injections for the...

Does statin use improve survival outcomes in men with advanced prostate cancer undergoing androgen deprivation therapy?

Posted by Medivizor on Sep 17, 2023 in Prostate cancer | 0 comments

In a nutshell This study evaluated the association between statin (cholesterol-lowering drugs) use and survival outcomes in men with advanced prostate cancer (PC) undergoing androgen deprivation therapy (ADT). The data showed that statin use improved the survival outcomes in these patients. Some background Metastatic prostate cancer (PC) is a form of...

Reducing chemotherapy-induced toxicities in patients with breast cancer using anti-diabetes medication metformin.

Posted by Medivizor on Sep 17, 2023 in Breast cancer | 0 comments

In a nutshell This study investigated the beneficial effects of co-administering anti-diabetes medication metformin (Glucophage) and doxorubicin (Adriamycin)-cyclophosphamide (Cytoxan) with paclitaxel (Taxol) (AC-T) chemotherapy in non-diabetic patients with breast cancer (BC). The data showed that metformin reduced the occurrence and severity of...

Treatment Posts on Medivizor

Evaluating the long-term effectiveness and safety of adding abiraterone acetate and prednisolone with or without enzalutamide in patients with metastatic prostate cancer starting androgen-deprivation therapy.

Evaluating the effects of dance style and training duration in improving balance in patients with Parkinson’s disease.

Evaluating the effectiveness and safety of immune checkpoint inhibitors given before surgery for the treatment of resectable mucosal melanoma.

Comparing the effectiveness and safety of chemotherapy-based combination therapies as first-line treatment for advanced non-small cell lung cancer with negative PD-L1.

Evaluating the effectiveness and safety of TAS-102 plus Yttrium-90 radioembolization for the treatment of patients with colorectal cancer liver metastasis.

Evaluating the effectiveness of antibiotic bone cement for infected diabetic foot wounds

Comparing the effectiveness of combined therapy of bortezomib, melphalan, and prednisone with versus without daratumumab in patients with multiple myeloma ineligible for a transplant

Evaluating the long-term effectiveness and safety of nivolumab and AVD chemotherapy combination in patients with early-stage unfavorable classical Hodgkin lymphoma.

Evaluating the effectiveness and safety of continuous subcutaneous foslevodopa-foscarbidopa for the treatment of motor fluctuations in patients with Parkinson’s disease.

Comparing the effectiveness and safety of 5 injections of OnabotulinumtoxinA versus the standard 20 injections for the treatment of patients with overactive bladder.

Does statin use improve survival outcomes in men with advanced prostate cancer undergoing androgen deprivation therapy?

Reducing chemotherapy-induced toxicities in patients with breast cancer using anti-diabetes medication metformin.

Categories

Recent Posts

Archives

Treatment Posts on Medivizor

Categories

Recent Posts

Archives

Thanks for your interest in Medivizor

Invalid email